Abbott Laboratories (ABT)

ABT (NYSE:Health Services) EQUITY
$50.69
pos +0.00
+0.00%
Today's Range: 50.60 - 51.13 | ABT Avg Daily Volume: 4,950,800
Last Update: 07/31/15 - 4:03 PM EDT
Volume: 0
YTD Performance: 12.59%
Open: $0.00
Previous Close: $50.77
52 Week Range: $39.28 - $51.74
Oustanding Shares: 1,488,757,318
Market Cap: 75,584,209,035
6-Month Chart
TheStreet Ratings Grade for ABT
Buy Hold Sell
A+ A A- B+ B B- C+ C C- D+ D D- E+ E E- F
TheStreet Ratings is the source for accurate ratings that you can rely upon to make sound, informed financial decisions. Click here to find out about our methodology.
Analysts Ratings
Historical Rec Current 1 Mo. Ago 2 Mo. Ago 3 Mo. Ago
Strong Buy 9 9 9 9
Moderate Buy 3 3 3 3
Hold 5 5 5 5
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.74 1.74 1.74 1.74
Latest Dividend: 0.24
Latest Dividend Yield: 1.89%
Dividend Ex-Date: 07/13/15
Price Earnings Ratio: 38.17
Price Earnings Comparisons:
ABT Sector Avg. S&P 500
38.17 17.00 25.63
Price Performance History (%Change):
3 Mo 1 Yr 3 Y
9.20% 20.35% 52.89%
GROWTH 12 Mo 3 Yr CAGR
Revenue -7.30 -0.48 -0.19
Net Income -11.30 -0.64 -0.28
EPS -8.00 -0.50 -0.21
Earnings for ABT:
EBITDA 4.15B
Revenue 20.25B
Average Earnings Estimates
Qtr (09/15) Qtr (12/15) FY (12/15) FY (12/16)
Average Estimate $0.54 $0.63 $2.16 $2.42
Number of Analysts 12 10 15 15
High Estimate $0.55 $0.65 $2.18 $2.46
Low Estimate $0.53 $0.62 $2.14 $2.35
Prior Year $0.62 $0.71 $2.28 $2.16
Growth Rate (Year over Year) -13.58% -10.99% -5.38% 12.08%
Chart Benchmark Timeframe
Average Frequency Indicator Chart
Scale Symbol Comparison Bollinger Bands
IBM and UTX accounted for two-thirds of the Dow's 1% drop, and Apple and Microsoft fall after-hours..
This market is almost entirely special situation.
Duke Energy's recent increase puts its payout at the high end of the industry range.
As health-care stocks rally, it's time for politicians to move on.
The ABBV chart looks constructive, with solid volume and bullish indicators.
You could throw darts at financials and health care and win. 
Update
Apr 24, 2015 | 6:48 AM EDT
ABT - Abbott Laboratories Annual Shareholders Meeting - 10AM
And have we mentioned Greece?

Earnings Growth Boosts AbbVie Real Money Pro($)

Drug franchises are still going strong.
The logic of owning the pure play is attractive.

REAL MONEY'S BEST IDEAS

News Breaks

Powered by

Columnist Tweets

BROKERAGE PARTNERS

Except as otherwise indicated, quotes are delayed. Quotes delayed at least 20 minutes for all exchanges. Market Data provided by Interactive Data. Company fundamental data provided by Morningstar. Earnings and ratings provided by Zacks. Mutual fund data provided by Valueline. ETF data provided by Lipper. Powered and implemented by Interactive Data Managed Solutions.


TheStreet Ratings updates stock ratings daily. However, if no rating change occurs, the data on this page does not update. The data does update after 90 days if no rating change occurs within that time period.

IDC calculates the Market Cap for the basic symbol to include common shares only. Year-to-date mutual fund returns are calculated on a monthly basis by Value Line and posted mid-month.